Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.22747 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.18097 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.18242 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.13635 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.14625 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.20909 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.17993 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.50623 | 22 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.15341 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.17032 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.16342 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.16449 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.16936 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.17 | 8 |